ANI Pharmaceuticals supplements proxy statement on stock plan share reserve

ANI PHARMACEUTICALS INC

As of March 24, 2025, total stock options outstanding: 571,880 (weighted avg exercise price $46.28, remaining term 3.68 yrs).
Performance/restricted stock awards: 1,866,153 shares; shares available for future grant: 1,177,800.
Inducement grants (non-shareholder approved) comprise 184,989 options at avg exercise price $29.63, term 5.57 yrs.
Company seeks approval of Amended and Restated 2022 Stock Incentive Plan; no changes to other proposals or meeting date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.